PTGS2 and neoplasm: ELAVL1 could promote the proliferation of tumor cells by directly binding ER or regulating epidermal growth factor receptor-2 (ERBB2), cyclooxygenase-2 (COX-2) and VEGF-A through a series of signal transduction pathways [43].